31 /100
MEDIUM RISK
Score updated Apr 13, 2026

NSRX

Nasus Pharma Ltd. — Stock Dilution Tracker

Track NSRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track NSRX — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
40
📊 Float Risk
42
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NSRX.
🔔 Track NSRX — Get forecast alerts →
💹 Market Data
Market Cap$25.76M
Shares Outstanding11.71M
Float5.53M
Cash$4.29M
Debt$118.0K
Short InterestN/A
🏛 Institutional Holdings
2 institutional holders · 2.4K shares
#1 Morgan Stanley 2.0K shares
#2 UBS Group AG 378 shares
📉 Short Interest
Short Interest99.2K
Days to Cover1.0
% of Float1.8%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track NSRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NSRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required